Xilio Therapeutics (XLO) Assets (QoQ) (2021 - 2026)
Xilio Therapeutics (XLO) Assets (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn |
| 10 | Xilio Therapeutics | 145.98 Mn | -4.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.69% |
| Dec 31, 2025 | 15.70% |
| Sep 30, 2025 | -0.09% |
| Jun 30, 2025 | 29.02% |
| Mar 31, 2025 | 45.92% |
| Dec 31, 2024 | -4.80% |
| Sep 30, 2024 | -16.93% |
| Jun 30, 2024 | 8.79% |
| Mar 31, 2024 | 35.59% |
| Dec 31, 2023 | -21.73% |
| Sep 30, 2023 | -15.72% |
| Jun 30, 2023 | -17.17% |
| Mar 31, 2023 | -19.88% |
| Dec 31, 2022 | -11.59% |
| Sep 30, 2022 | -11.63% |
| Jun 30, 2022 | -9.28% |
| Mar 31, 2022 | -9.96% |
| Dec 31, 2021 | 80.63% |